Annexes to the recommendations for use of the CanSinoBIO Ad5-nCoV-S [‎recombinant]‎ vaccine (‎Convidecia™)‎ against COVID-19

Annexes to the recommendations for use of the CanSinoBIO Ad5-nCoV-S [‎recombinant]‎ vaccine (‎Convidecia™)‎ against COVID-19: grading of evidence: evidence to recommendation tables, first issuance: 19 May 2022

Authors